Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026
Go back to Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026| (NASDAQ: KNSA) | Delayed: 78.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.08 | 52 Week High | $ | |||
| Open | $78.08 | 52 Week Low | $ | |||
| Day High | $78.08 | P/E | N/A | |||
| Day Low | $78.08 | EPS | $ | |||
| Volume | 464 | |||||

